ENTRY       D10377                      Drug
NAME        Sebelipase alfa (USAN);
            Sebelipase alfa (genetical recombination) (JAN);
            Kanuma (TN)
PRODUCT     KANUMA (Alexion Pharmaceuticals)
FORMULA     C1968H2945N507O551S15
EXACT_MASS  42976.3823
MOL_WEIGHT  43003.4822
SEQUENCE    SGGKLTAVDP ETNMNVSEII SYWGFPSEEY LVETEDGYIL CLNRIPHGRK NHSDKGPKPV
            VFLQHGLLAD SSNWVTNLAN SSLGFILADA GFDVWMGNSR GNTWSRKHKT LSVSQDEFWA
            FSYDEMAKYD LPASINFILN KTGQEQVYYV GHSQGTTIGF IAFSQIPELA KRIKMFFALG
            PVASVAFCTS PMAKLGRLPD HLIKDLFGDK EFLPQSAFLK WLGTHVCTHV ILKELCGNLC
            FLLCGFNERN LNMSRVDVYT THSPAGTSVQ NMLHWSQAVK FQKFQAFDWG SSAKNYFHYN
            QSYPPTYNVK DMLVPTAVWS GGHDWLADVY DVNILLTQIT NLVFHESIPE WEHLDFIWGL
            DAPWRLYNKI INLMRKYQ
            (glycosylation sites (N) :Asn-15, Asn-80, Asn-140, Asn-252,
            Asn-300)
  TYPE      Peptide
REMARK      Therapeutic category: 3959
            ATC code: A16AB14
            Product: D10377<JP/US>
EFFICACY    Lysosomal storage disease treatment, Enzyme replacement (lysosomal acid lipase)
  DISEASE   Lysosomal acid lipase deficiency [DS:H00148]
  TYPE      Enzyme replacement therapy product
TARGET      LIPA* [HSA_VAR:3988v1] [HSA:3988] [KO:K01052]
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AB Enzymes
                 A16AB14 Sebelipase alfa
                  D10377  Sebelipase alfa (USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Sebelipase Alfa
               D10377  Sebelipase alfa (USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               395  Enzyme preparations
                3959  Others
                 D10377  Sebelipase alfa (USAN); Sebelipase alfa (genetical recombination) (JAN)
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Hydrolases (EC3)
               Carboxylic-ester hydrolases
                LIPA* [HSA_VAR:3988v1]
                 D10377  Sebelipase alfa (USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10377
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10377
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10377
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10377
            Pharmacogenomic biomarkers [br08341.html]
             Germline mutations in genetic disorder treatments
              D10377
DBLINKS     CAS: 1276027-63-4
            PubChem: 172232470
///
